Allergan Sales recalls
FDA enforcement reports naming Allergan Sales, LLC as the recalling firm.
- Recall reports
- 13
- Class I (serious)
- 0
- Most recent report
- Apr 3, 2019
- Apr 3, 2019Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0Drug · Allergan Sales, LLCcGMP DeviationsClass II
- Nov 22, 2017Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0Drug · Allergan Sales, LLCFailed Impurities/Degradation Specifications.Class III
- Nov 22, 2017Lumigan (bimatoprost ophthalmic solution) 0Drug · Allergan Sales, LLCFailed Impurities/Degradation Specifications.Class III
- Jul 5, 2017Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0Drug · Allergan Sales, LLCFailed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.Class II
- Apr 19, 2017Lumigan (bimatoprost ophthalmic solution) 0Drug · Allergan Sales, LLCFailed Impurities/Degradation SpecificationsClass III
- Oct 19, 2016TAZORAC (tazarotene) Gel 0Drug · Allergan Sales, LLCFailed Content Uniformity SpecificationsClass II
- Oct 19, 2016TAZORAC (tazarotene) Gel 0Drug · Allergan Sales, LLCFailed Content Uniformity SpecificationsClass II
- Jul 13, 2016Tazorac (tazarotene) Gel 0Drug · Allergan Sales, LLCFailed Content Uniformity Specifications.Class II
- Jul 13, 2016Tazorac (tazarotene) Gel 0Drug · Allergan Sales, LLCFailed Content Uniformity Specifications.Class II
- Sep 30, 2015Refresh Lacri-Lube (Mineral Oil 42Drug · Allergan Sales, LLCPresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially intr…Class II
- FML (fluorometholone ophthalmic ointment) 0
- BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0
- Refresh P
Page 1 of 2